AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)
AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)

Discounted Cash Flow (DCF) Analysis Unlevered

KalVista Pharmaceuticals Inc. Quote

KalVista Pharma (KALV)

28.90 -0.03 Healthcare
All | Operating Data | Balance Sheet Data | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results

Operating Data KALV Quote KalVista Ph

Balance Sheet Data KALV Quote KalVista Ph

Weighted Average Cost Of Capital KALV Quote KalVista Ph

Share Price $ 28.9
Diluted Shares Outstanding 1
Cost of Debt
Tax Rate -
After-tax Cost of Debt 5.0
Risk Free Rate
Market Risk Premium
Cost of Equity 22.06
Total Debt 0.00
Total Equity 289.00
Total Capital 289.00
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash KALV Quote KalVista Ph

Terminal Value KALV Quote KalVista Ph

Growth in perpetuity method:
Long term growth rate
WACC (%) 22.1
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value KALV Quote KalVista Ph

Enterprise Value -
Net Debt -51
Equity Value -
Shares Outstanding 10
Equity Value Per Share -

Results Unlevered DCF KALV Quote KalVista Ph